Kellyn Engstrom, Pharm.D., MPH (@KellynEPharmD) reports on current guideline recommendations and gaps in evidence for the treatment of status epilepticus, interprets recent evidence regarding conventional antiepileptic utilization in status epilepticus, and lists three considerations in applying new evidence for status epilepticus treatment into clinical practice.

For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter!

You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.